Research from the University of Southern California has developed a new nanoparticle-based vaccine candidate for protection against tick-borne diseases. This groundbreaking new vaccine candidate is set to revolutionize the way we protect ourselves against tick-borne illnesses. The nanoparticle vaccine candidate is made up of a combination of small pieces of proteins from several tick-borne diseases, which are then delivered to the body via a nanoparticle. This novel approach to vaccination could help to protect us from a range of different diseases, including Lyme Disease, Rocky Mountain spotted fever, and other illnesses caused by ticks. The nanoparticle vaccine candidate has already proven effective in animal studies, and researchers are now preparing to move into human trials. This groundbreaking research could provide a new way of protecting against tick-borne diseases, and potentially improve the quality of life for many people around the world.

Read Full Article Here

source: Phys.org